Weight Gain, Raised BP Risk Seen for HIV Patients Switching to Dolutegravir

For Black patients with HIV on antiretroviral therapy (ART), those who switch from efavirenz to dolutegravir gain more weight and have an increased risk for hypertension,  Read More